Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC25A20 |
| Upstream (Parents) |
|---|
| (<<) CYP27A1 → SLC25A20 |
| (<<) PRODH2 → SLC25A20 |
| (<<) FAH → SLC25A20 |
| Downstream (Children) |
|---|
| SLC25A20 → SEC61A2 (>>) |
| SLC25A20 → SLC6A12 (>>) |
| SLC25A20 → IGFALS (>>) |
| SLC25A20 → MEP1B (>>) |
| SLC25A20 → DPY19L2P2 (>>) |
| SLC25A20 → PGP (>>) |
| SLC25A20 → BAZ2A (>>) |
| SLC25A20 → GPC4 (>>) |
| SLC25A20 → ACAA2 (>>) |
| SLC25A20 → TTC26 (>>) |
| SLC25A20 → CSNK1E (>>) |
| SLC25A20 → SLC46A3 (>>) |
| SLC25A20 → RPS9 (>>) |
| SLC25A20 → AMT (>>) |
| SLC25A20 → RPS6KA5 (>>) |
